Survey Uncovers Disconnect Related to Perception of Psoriasis Severity

Dr. Mark Lebwohl, Professor and Chair of the Department of Dermatology at Mount Sinai Hospital in New York, sat down with Sven Richter, Amgen Global Medical Affairs Lead, to discuss key takeaways from the recent Understanding Psoriasis Leveraging Insight for Treatment (UPLIFT) survey, presented virtually at the Winter Clinical Dermatology Conference. Dr. Lebwohl addressed the disconnect between people with psoriasis’ perception of disease severity and common severity assessment measures such as body surface area (BSA) and how to improve patient care in the future.